| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 20,378,000 | 18,633,500 | 15,691,000 | | Cost of Revenue | 4,382,800 | 4,248,800 | 3,546,500 | | | Gross Profit | 15,995,200 | 14,384,700 | 12,144,500 | | | Operating Expenses | | Research Development | 3,840,900 | 3,486,700 | 3,129,300 | | Selling General and Administrative | 6,626,400 | 6,095,100 | 4,889,800 | | Non Recurring | 6,809,400 | 1,048,100 | 945,200 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,281,500) | 3,754,800 | 3,180,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 202,200 | 350,300 | 379,600 | | Earnings Before Interest And Taxes | (1,079,300) | 4,105,100 | 3,656,100 | | Interest Expense | 228,300 | 228,300 | 238,100 | | Income Before Tax | (1,307,600) | 3,876,800 | 3,418,000 | | Income Tax Expense | 764,300 | 923,800 | 755,300 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,071,900) | 2,953,000 | 2,662,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,071,900) | 2,953,000 | 2,662,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,071,900) | $2,953,000 | $2,662,700 |
|
0.16% Nasdaq 0.00%
Income Statement
